Lipoprotein-Associated Phospholipase A ₂

This publication has 17 references indexed in Scilit:

• Lipoprotein-Associated Phospholipase A ₂ and Prognosis After Myocardial Infarction in the Community
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
• Lipoprotein-Associated Phospholipase A ₂ Protein Expression in the Natural Progression of Human Coronary Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
• Lipoprotein-Associated Phospholipase A ₂ and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial
  Circulation, 2006
• Role of Lipoprotein-Associated Phospholipase A ₂ in Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke
  Circulation, 2005
• Association of Lipoprotein-Associated Phospholipase A ₂ Mass and Activity With Calcified Coronary Plaque in Young Adults
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Lipoprotein-Associated Phospholipase A ₂ Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population
  Circulation, 2004
• Lipoprotein-Associated Phospholipase A ₂ , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
  Circulation, 2004
• Lipoprotein-Associated Phospholipase A₂as an Independent Predictor of Coronary Heart Disease
  New England Journal of Medicine, 2000
• Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994